We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
(+14%)
Cap. Flow
+$2.65B
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$255M |
| 2 |
Apple
AAPL
|
+$173M |
| 3 |
Microsoft
MSFT
|
+$166M |
| 4 |
JPMorgan Chase
JPM
|
+$134M |
| 5 |
Amazon
AMZN
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$74.8M |
| 2 |
Accenture
ACN
|
+$70.7M |
| 3 |
Elevance Health
ELV
|
+$69.2M |
| 4 |
HES
Hess
HES
|
+$59.9M |
| 5 |
Motorola Solutions
MSI
|
+$53.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.07% |
| 2 | Financials | 13.98% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Communication Services | 10.11% |
| 5 | Healthcare | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNS
901
DELISTED
WNS Holdings
WNS
| – | – |
-8,207
| Closed | -$519K |
|
902
WillScot Mobile Mini Holdings
WSC
$4.8B
| – | – |
-452,732
| Closed | -$12.4M |
|
|
NBIS
903
Nebius Group N.V.
NBIS
$47.7B
| $0 | ﹤0.01% |
141,608
| – | – |
|
|
SNDK
904
Sandisk
SNDK
$213B
| – | – |
-4,853
| Closed | -$220K |
|
|
RAL
905
Ralliant Corp
RAL
$7.77B
| – | – |
-87,460
| Closed | -$4.24M |
|
Similar funds
QCM
NAMI
Aviva's Q3 2025 Portfolio in Review
As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.
- Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
- Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
- Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
- Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
- Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
- Aviva opened 47 new positions and closed 58 in Q3 2025.
- Aviva's portfolio value rose 14% quarter-over-quarter to $55B.
Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.